These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35031681)

  • 1. Subgroup analysis reveals higher reliability of the new comprehensive evaluation of Global Initiative for Chronic Obstructive Lung Disease 2019.
    Dai Z; Zeng H; Cui Y; Chen P; Chen Y
    Sci Rep; 2022 Jan; 12(1):757. PubMed ID: 35031681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in China.
    Sun L; Chen Y; Wu R; Lu M; Yao W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3095-3102. PubMed ID: 29118578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
    Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
    Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients.
    Song Q; Zhao YY; Zeng YQ; Liu C; Cheng W; Deng MH; Li X; Ma LB; Chen Y; Cai S; Chen P
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1401-1412. PubMed ID: 34040367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
    Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
    J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice.
    Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.
    Kim S; Oh J; Kim YI; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YC; Lim SC
    BMC Pulm Med; 2013 Jun; 13():35. PubMed ID: 23731868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.
    Huang WC; Wu MF; Chen HC; Hsu JY;
    NPJ Prim Care Respir Med; 2015 Nov; 25():15063. PubMed ID: 26538368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
    Han MK; Muellerova H; Curran-Everett D; Dransfield MT; Washko GR; Regan EA; Bowler RP; Beaty TH; Hokanson JE; Lynch DA; Jones PW; Anzueto A; Martinez FJ; Crapo JD; Silverman EK; Make BJ
    Lancet Respir Med; 2013 Mar; 1(1):43-50. PubMed ID: 24321803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
    Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
    Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.
    Högman M; Sulku J; Ställberg B; Janson C; Bröms K; Hedenström H; Lisspers K; Malinovschi A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():165-173. PubMed ID: 29379281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysis.
    Zhou Z; Zhou A; Zhao Y; Duan J; Chen P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1675-1682. PubMed ID: 29872285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reanalysis of the Japanese experience using the combined COPD assessment of the 2011 GOLD classification.
    Nishimura K; Oga T; Tsukino M; Hajiro T; Ikeda A; Jones PW
    Respir Investig; 2014 Mar; 52(2):129-35. PubMed ID: 24636269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of health status and its correlation with lung function in patients with chronic obstructive pulmonary disease: a study from a tertiary care center in north India.
    Gupta A; Garg K; Chopra V; Singh SP
    Monaldi Arch Chest Dis; 2023 Jun; 94(1):. PubMed ID: 37284775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management Reality of Female Patients with COPD: A Multicenter Cross-Sectional CAP Study in Japan.
    Yamamoto T; Oishi K; Ohata S; Murata Y; Yamaji Y; Asami-Noyama M; Edakuni N; Kakugawa T; Hirano T; Matsunaga K
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1123-1130. PubMed ID: 38803411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between objectively measured physical activity and morning symptoms in COPD.
    van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.